BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2776655)

  • 21. In vivo metabolism of ApoB, ApoA-I, and VLDL triglycerides in a form of hypobetalipoproteinemia not linked to the ApoB gene.
    Elias N; Patterson BW; Schonfeld G
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1309-15. PubMed ID: 10807747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of LDL-associated apolipoprotein B from measurements of triglycerides and total apolipoprotein B.
    Baca AM; Warnick GR
    Clin Chem; 2008 May; 54(5):907-10. PubMed ID: 18443176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet.
    Fisher WR; Zech LA; Stacpoole PW
    J Lipid Res; 1998 Feb; 39(2):388-401. PubMed ID: 9507999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein(a) is present in the triglyceride-rich fraction in type IV hypertriglyceridemia.
    Selinger E; Dallongeville J; Davignon J
    Clin Biochem; 1993 Feb; 26(1):59-64. PubMed ID: 8448841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells.
    McKeone BJ; Patsch JR; Pownall HJ
    J Clin Invest; 1993 May; 91(5):1926-33. PubMed ID: 8387537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ileal exclusion on kinetics of very low density lipoprotein triglycerides in familial hypercholesterolemia.
    Koivisto PV; Miettinen TA
    Clin Chim Acta; 1986 Nov; 161(1):91-101. PubMed ID: 3815857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics: studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet.
    Stacpoole PW; von Bergmann K; Kilgore LL; Zech LA; Fisher WR
    J Lipid Res; 1991 Nov; 32(11):1837-48. PubMed ID: 1770303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
    Rioja J; Ariza MJ; García-Casares N; Coca-Prieto I; Arrobas T; Muñiz-Grijalvo O; Mangas A; Ibarretxe D; Sánchez-Chaparro MÁ; Valdivielso P
    Eur J Clin Invest; 2020 Dec; 50(12):e13345. PubMed ID: 32649781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compensatory mechanisms governing the concentration of plasma low density lipoprotein.
    Howard BV; Egusa G; Beltz WF; Kesäniemi YA; Grundy SM
    J Lipid Res; 1986 Jan; 27(1):11-20. PubMed ID: 3958608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC; Watts GF; Nguyen MN; Barrett PH
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contents of apolipoprotein A-I, A-II and B of the human serum fractions for high-density and low-density lipoproteins prepared by common precipitation methods.
    Väisänen S; Gävert J; Julkunen A; Voutilainen E; Penttilä I
    Scand J Clin Lab Invest; 1992 Dec; 52(8):853-62. PubMed ID: 1488623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of simvastatin on the number and composition of apoproteinB-containing lipoproteins in hypercholesterolemia: analysis of apoproteinB in each lipoprotein fraction by highly sensitive latex method.
    Ikeda Ryomoto K; Suzuki M; Tsushima M; Yamamoto A; Harano Y
    Endocr J; 1996 Oct; 43(5):469-75. PubMed ID: 8980885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.